Pheochromocytoma With Langerhans Cell Histiocytosis: A Rare Tumor‐in‐Tumor Case
Clinical Case Reports · 2026-03 · 14 (3)
DOI: 10.1002/ccr3.72185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 26.02.2026. Verfasst von Cheng Lei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology The Second Xiangya Hospital, Central South University Changsha China. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Langerhans cell histiocytosis (LCH) occurring in a Pheochromocytoma in the adrenal gland is exceptionally rare and prone to misdiagnosis. The special coexistent tumors harbor distinct genetic mutations. This uncommon case could introduce novel considerations and a strong teaching message to all the clinicians and pathologists.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology The Second Xiangya Hospital, Central South University Changsha China.
- Department of Pathology Lixian Traditional Chinese Medicine Hospital Changde China.
- The Xiangya Medical School Central South University Changsha China.
ORCID-Profile: Jiadi Luo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Lei, C., Guo, Y., Luo, Y., Liang, Q., & Luo, J. (2026). Pheochromocytoma With Langerhans Cell Histiocytosis: A Rare Tumor‐in‐Tumor Case. Clinical Case Reports, 14(3). https://doi.org/10.1002/ccr3.72185
Vancouver
Lei C, Guo Y, Luo Y, Liang Q, Luo J. Pheochromocytoma With Langerhans Cell Histiocytosis: A Rare Tumor‐in‐Tumor Case. Clinical Case Reports. 2026;14(3). doi:10.1002/ccr3.72185
BibTeX
@article{Lei2026,
author = {Lei, Cheng and Guo, Yulong and Luo, Yixin and Liang, Qingchun and Luo, Jiadi},
title = {Pheochromocytoma With Langerhans Cell Histiocytosis: A Rare Tumor‐in‐Tumor Case},
journal = {Clinical Case Reports},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/ccr3.72185}
}
EUVIMED